Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Dec;28(12):2726–2732. doi: 10.1128/jcm.28.12.2726-2732.1990

Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica.

R J Wallace Jr 1, M Tsukamura 1, B A Brown 1, J Brown 1, V A Steingrube 1, Y S Zhang 1, D R Nash 1
PMCID: PMC268263  PMID: 2280003

Abstract

A recent study of Nocardia asteroides revealed that 95% of clinical strains had one of five antibiotic resistance patterns. We found the pattern of resistance to cefotaxime and cefamandole in 19% of 200 clinical N. asteroides isolates. Isolates with this drug resistance pattern were from numerous geographic sources and were associated with significant clinical disease (56% of patients had disseminated infections). Phenotypic studies revealed that these isolates were relatively homogeneous and matched previous descriptions and reference strains of the controversial species N. farcinica. Growth at 45 degrees C, acid production from rhamnose, ability to utilize acetamide as a nitrogen and carbon source, and resistance to tobramycin and cefamandole were features of N. farcinica that could be tested in the clinical laboratory and allowed their distinction from N. asteroides. The serious nature of disease due to N. farcinica and its resistance to the newer cephalosporins suggest a clinical need for laboratory identification of this species. (Current tests used in clinical laboratories do not distinguish N. farcinica from N. asteroides.) This is the first recognition that N. farcinica has a specific drug resistance pattern and confirms the previously described concept that drug resistance patterns of N. asteroides may be associated with specific taxonomic groups.

Full text

PDF
2726

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berd D. Nocardia asteroides. A taxonomic study with clinical correlations. Am Rev Respir Dis. 1973 Oct;108(4):909–917. doi: 10.1164/arrd.1973.108.4.909. [DOI] [PubMed] [Google Scholar]
  2. Boiron P., Provost F. In-vitro susceptibility testing of Nocardia spp. and its taxonomic implication. J Antimicrob Chemother. 1988 Nov;22(5):623–629. doi: 10.1093/jac/22.5.623. [DOI] [PubMed] [Google Scholar]
  3. GORDON R. E., MIHM J. M. A comparative study of some strains received as nocardiae. J Bacteriol. 1957 Jan;73(1):15–27. doi: 10.1128/jb.73.1.15-27.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GORDON R. E., MIHM J. M. The type species of the genus Nocardia. J Gen Microbiol. 1962 Jan;27:1–10. doi: 10.1099/00221287-27-1-1. [DOI] [PubMed] [Google Scholar]
  5. Gombert M. E., Aulicino T. M. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother. 1983 Nov;24(5):810–811. doi: 10.1128/aac.24.5.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goodfellow M., Orchard V. A. Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy. J Gen Microbiol. 1974 Aug;83(2):375–387. doi: 10.1099/00221287-83-2-375. [DOI] [PubMed] [Google Scholar]
  7. Holm P. Seven cases of human nocardiosis caused by Nocardia farcinica. Sabouraudia. 1975 Jul;13(2):161–169. [PubMed] [Google Scholar]
  8. Kitzis M. D., Gutmann L., Acar J. F. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. J Antimicrob Chemother. 1985 Jan;15(1):23–30. doi: 10.1093/jac/15.1.23. [DOI] [PubMed] [Google Scholar]
  9. Kurup P. V., Schmitt J. A. Numerical taxonomy of Nocardia. Can J Microbiol. 1973 Aug;19(8):1035–1048. doi: 10.1139/m73-164. [DOI] [PubMed] [Google Scholar]
  10. Magnusson M., Mariat F. Delineation of Nocardia farcinica by delayed type skin reactions on guinea pigs. J Gen Microbiol. 1968 Apr;51(1):151–158. doi: 10.1099/00221287-51-1-151. [DOI] [PubMed] [Google Scholar]
  11. Mishra S. K., Gordon R. E., Barnett D. A. Identification of nocardiae and streptomycetes of medical importance. J Clin Microbiol. 1980 Jun;11(6):728–736. doi: 10.1128/jcm.11.6.728-736.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Orchard V. A., Goodfellow M. Numerical classification of some named strains of Nocardia asteroides and related isolates from soil. J Gen Microbiol. 1980 Jun;118(2):295–312. doi: 10.1099/00221287-118-2-295. [DOI] [PubMed] [Google Scholar]
  13. Tsukamura M. Differentiation between genera Rhodococcus and Nocardia by susceptibility testing to kanamycin and some other antituberculosis agents. Microbiol Immunol. 1988;32(4):441–445. doi: 10.1111/j.1348-0421.1988.tb01404.x. [DOI] [PubMed] [Google Scholar]
  14. Tsukamura M. Nocardiae that recently caused lung infection in Japan--Nocardia asteroides and Nocardia farcinica. Microbiol Immunol. 1982;26(4):341–345. doi: 10.1111/j.1348-0421.1982.tb00183.x. [DOI] [PubMed] [Google Scholar]
  15. Tsukamura M. Numerical analysis of the taxonomy of Nocardiae and Rhodococci. Microbiol Immunol. 1982;26(12):1101–1119. doi: 10.1111/j.1348-0421.1982.tb00260.x. [DOI] [PubMed] [Google Scholar]
  16. Tsukamura M. Numerical taxonomy of the genus Nocardia. J Gen Microbiol. 1969 Jun;56(3):265–287. doi: 10.1099/00221287-56-3-265. [DOI] [PubMed] [Google Scholar]
  17. Tsukamura M., Shimoide H., Kaneda K., Sakai R., Seino A. A case of lung infection caused by an unusual strain of Nocardia farcinica. Microbiol Immunol. 1988;32(5):541–546. doi: 10.1111/j.1348-0421.1988.tb01415.x. [DOI] [PubMed] [Google Scholar]
  18. Wallace R. J., Jr, Nash D. R., Johnson W. K., Steele L. C., Steingrube V. A. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid. J Infect Dis. 1987 Dec;156(6):959–966. doi: 10.1093/infdis/156.6.959. [DOI] [PubMed] [Google Scholar]
  19. Wallace R. J., Jr, Steele L. C., Sumter G., Smith J. M. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother. 1988 Dec;32(12):1776–1779. doi: 10.1128/aac.32.12.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wallace R. J., Jr, Steele L. C. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis. 1988 Mar;9(3):155–166. doi: 10.1016/0732-8893(88)90025-9. [DOI] [PubMed] [Google Scholar]
  21. Wallace R. J., Jr, Wiss K., Curvey R., Vance P. H., Steadham J. Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy. Antimicrob Agents Chemother. 1983 Jan;23(1):19–21. doi: 10.1128/aac.23.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES